POH are solidly and consistently moving forward to commercialize a seven day OXYPATCH that is abuse proof and very effective chronic pain treatment.
This will be a world first for opiod drugs and a Blockbuster for POH. We ill own it a 100 percent and the sales potential is a bout 5 billion globally.
Whilst we own it better than 60 % of revenue will flow back to POH coffers. This is a company maker and we are getting very close.
PoS
phosphagenics collaborates with 3m to develop , page-32
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $408 | 154.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 61 | 90794613 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 54998583 | 13 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |